Genovare Pre-Filled Pen Premixed Aqueous

Specs

Buy PT-141 50mg AQ Pen in Dubai

Melanocortin agonist tested in phase 3 trials

AED 700 / pen

In stock 50 mg Aqueous pre-filled pen

Catalogue strength
50 mg
Format
Aqueous pre-filled pen
Pack size
3mL
Purity
99%+

Choose your bundle

Add AED 300 more for free UAE delivery

  1. OrderBefore 4 PM for Dubai
  2. PackedCold-chain, 2–8°C
  3. DeliveredSame day in Dubai, next day elsewhere in the UAE

Order before 4 PM for same-day Dubai delivery.

UAE delivery: AED 50 below AED 1,000; free from AED 1,000

Pay byCard payment linkUSDT

99%+ purityIn-house tested

See every published lab report

Sold by
Remy Research
Manufacturer
Genovare
Tested by
99%+ line standard
  • 99%+ purityLine standard
  • Same-day DubaiOrder before 4 PM for same-day delivery
  • FormatAqueous pre-filled pen
  • Cold-chain packed2–8°C

Genovare PT 141 50mg Pen: What the Research Shows

  • Average desire gain 0.5–0.6 vs 0.2 placebo
  • Average distress drop 0.7 vs 0.4 placebo
  • Desire gains held across 52 weeks

Published study results for the compound, not results from this product. For research use only.

Genovare PT 141 50mg Pen is a 3mL aqueous pre-filled research pen containing 50 mg of PT-141 (bremelanotide), a synthetic melanocortin receptor agonist supplied for in-vitro laboratory research rather than approved medical use.

For researchers and scientists who need clear product specifications before ordering, this page brings together the details that affect handling and study planning: 99%+ purity, pen format, pack size, cold-chain delivery, storage conditions, chemical and product data, comparisons with related options, research context, regulatory status, and UAE ordering information.

Genovare PT 141 50mg pen is a Genovare-labelled 3mL pre-filled aqueous research pen containing a catalogue strength of 50 mg PT-141 (bremelanotide), a synthetic melanocortin receptor agonist; it is presented here for in-vitro laboratory research only and not as an approved medicine. This page is written for researchers and scientists who need a clear snapshot of the product’s stated format, and how it differs from authorised bremelanotide products.

PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide studied as an agonist at several melanocortin-receptor subtypes. The Genovare 3mL pen is labelled 50mg, but no sequence, salt or formulation-equivalence evidence is supplied. You’ll also find the key handling and buying details researchers usually check first: stated specifications, storage guidance, what is included, delivery context in the UAE, and the compound’s research and regulatory status, including its distinction from approved medicines such as Vyleesi.

Compound: PT-141 (bremelanotide) Catalogue strength: 50 mg Format: Aqueous pre-filled pen Storage: Follow the Genovare package label.
Pack Size
3mL
Product details
Genovare Catalogue
Pre-Filled Pen
Premixed Aqueous
Storage Guidance
Follow Package Label
What Is Included
  • 1 pre-filled Genovare research pen
  • 3 pen needles
  • Genovare retail packaging

Other formats of PT-141

Also available

Ships from Dubai

All Peptides

PT-141 50mg AQ Pen: what it is

PT-141, or bremelanotide, is a synthetic cyclic seven-amino-acid peptide that activates melanocortin receptors. It is closely related to Melanotan II: the two share the same ring, and bremelanotide carries a free acid at its C-terminus where Melanotan II carries an amide.

Genovare supplies this pen ready-made: the peptide is already dissolved in an aqueous solution, and the catalogue lists it at 50 mg in a 3mL fill. Bremelanotide is the active substance of Vyleesi, a prescription medicine in the US, but this pen is a separate Genovare product, and the Vyleesi label's quality and safety data do not apply to it.

No regulator has approved this pen as a medicine. Remy Research sells it for in-vitro laboratory research only, not for human or veterinary use.

Batch status, storage and delivery

Batch status

Its testing line reads "99%+ line standard". Every report published so far is listed in the lab results library.

Storage and handling

Remy Research ships this pen cold-chain packed at 2–8°C, with live order tracking. After delivery, store it as the Genovare pack label directs: the label, not a general rule, sets the conditions for this product.

The peptide is already in solution, and supplier guides say a peptide solution tolerates heat far less well than dry powder; they also advise keeping peptides away from bright light. The stretch between the door and storage is the part the cold chain does not cover. A parked car in a UAE summer runs well above 40°C, the temperature of the accelerated condition (40°C at 75% relative humidity) in the ICH Q1A(R2) pharmaceutical stability-testing guideline, so a car is not a holding place even for a short errand.

If the pen spends time outside its labelled range, note how long and how warm it got. A clear solution is not proof of quality: only a retest, for example by HPLC, shows whether the peptide has changed. The peptide storage and shelf-life guide sets out the sourced figures.

Delivery in the UAE

Dubai orders placed before 4 PM are delivered the same day. In the other emirates, orders placed before 12 PM (noon) arrive the next day, otherwise within two days, and Saturday orders outside Dubai arrive on Monday. Delivery costs AED 50 below AED 1,000 and is free from AED 1,000; the minimum order is AED 400. Full terms are on the delivery page.

PT-141 chemistry & specifications

Identity

Cyclic melanocortin-receptor agonist peptide

Bremelanotide (PT-141)

Also known asBremelanotide, PT141, PT 141

CAS
189691-06-3

Molecule

Formula
C50H68N14O10
Molecular weight
1,025.2 g/mol Registry value for the peptide without counter-ions; not measured for this batch.
Sequence
7 residues · cyclic: lactam bridge Asp2–Lys7, N-terminal acetylAc-Nle-Asp-His-D-Phe-Arg-Trp-Lys
Note
Nle is norleucine.

This product

Manufacturer
Genovare
Catalogue strength
50 mg
Fill volume
3mL
Format
Aqueous pre-filled pen
Pack size
1 pen with 3 needles

Batch documentation

99%+ line standard

Every report we have published is listed in the lab results library.

Reference data for laboratory checks. Registry values describe the compound, not measurements of this batch. For research use only.

What the literature says

Bremelanotide holds an FDA approval: Vyleesi was approved on 21 June 2019 for premenopausal women with acquired, generalized hypoactive sexual desire disorder that is not due to another medical or psychiatric condition, a relationship problem or a medicine. It is thought to act on the central nervous system, specifically the hypothalamus, and to alter neurotransmitter signaling in the brain, including dopamine pathways, to influence sexual motivation and response rather than directly increasing blood flow, although the Vyleesi label states that its mechanism is unknown. Common side effects listed on the Vyleesi label include nausea, flushing, and headaches, and temporary blood pressure increases with heart rate decreases may occur. That approval covers Vyleesi in that population, not this pen. The PT-141 research review covers the trial record and the melanocortin biology. Off-label use for erectile dysfunction in men has been investigated, but effectiveness is less established and it is not approved for enhancing overall sexual performance.

Frequently Asked Questions

What are the chemical identifiers of PT-141?

Bremelanotide (PT-141) has CAS number 189691-06-3, molecular formula C50H68N14O10, molecular weight 1,025.2 g/mol, PubChem CID 9941379. These are registry values for the compound, not measurements of a batch.

Which PT-141 formats have a published batch report?

Among the related formats Remy Research lists, published Janoshik reports exist for the ProPeptide PT-141 20mg Pen (batch PT20P-001). Every published report is listed in the lab results library.

How does this pen differ from the other formats?

This Genovare pen holds 50 mg as an aqueous solution in a pre-filled pen. Remy Research also lists 2 related formats from ProPeptide; the comparison table on this page sets out their compounds, formats and batch documentation.

How is this pen shipped and stored?

Remy Research ships it cold-chain packed at 2–8°C, with live order tracking. After delivery, the storage conditions printed on the Genovare pack apply. The peptide is already in solution, which tolerates heat far less well than dry powder, so keep the pen out of bright light and out of parked cars.

Is this pen the same as Vyleesi?

No. Bremelanotide (PT-141) is the active substance of Vyleesi, which FDA approved in 2019 for acquired, generalized hypoactive sexual desire disorder in premenopausal women. This pen is a separate Genovare product, and no regulator has approved it as a medicine. Remy Research sells it for in-vitro laboratory research only, not for human or veterinary use.

How fast is delivery in the UAE?

Dubai orders placed before 4 PM are delivered the same day. In the other emirates, orders placed before 12 PM (noon) arrive the next day, otherwise within two days, and Saturday orders outside Dubai arrive on Monday. Delivery costs AED 50 below AED 1,000 and is free from AED 1,000; the minimum order is AED 400.

Does Remy Research sell PT-141 nasal spray?

Remy Research lists PT-141 in three formats: this Genovare 50mg aqueous pre-filled pen (3mL, AED 700), a ProPeptide 20mg pen and a ProPeptide 10mg vial. A nasal spray is not listed. The ProPeptide 20mg pen has a published Janoshik report, batch PT20P-001. All are sold for in-vitro laboratory research only.

Can I buy the Genovare PT-141 50mg AQ pen online in the UAE?

Remy Research, a Dubai-based supplier, lists the Genovare PT-141 50mg AQ pen at AED 700 for in-vitro laboratory research only. Ordering takes place on the website. Delivery reaches all seven emirates. A minimum order of AED 400 applies, and no walk-in store or pickup point exists.